Important Drug-Drug Interactions in the Elderly

被引：0
|
作者：
Ruth M. Seymour
Philip A. Routledge
机构：
[1] University of Wales College of Medicine,Department of Pharmacology, Therapeutics and Toxicology
来源：
Drugs & Aging | 1998年 / 12卷
关键词：
Warfarin; Nursing Home; Drug Interaction; Adis International Limited; Amiodarone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Although drug-drug interactions constitute only a small proportion of adverse drug reactions, they are important because they are often predictable and therefore avoidable or manageable. Their frequency is related to the age of the patient, the number of drugs prescribed, the number of physicians involved in the patient’s care and the presence of increasing frailty.
引用
收藏
页码：485 / 494
页数：9
相关论文
共 50 条
  • [21] Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao
    Lao, Cheng Kin
    Ho, Sao Chan
    Chan, Ka Kit
    Tou, Chon Fai
    Tong, Henry Hoi Yee
    Chan, Alexandre
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 805 - 812
  • [22] Drug-Drug Interactions among Elderly Patients at Hospital Discharge: A Cross-Sectional Descriptive Study
    Balodiya, Sujit
    Kamath, Ashwin
    Shastry, Rajeshwari
    Chowta, Mukta N.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2019, 8 (03) : 88 - 95
  • [23] Drug-drug interactions involving new antiretroviral drugs and drug classes
    Soodalter, Jesse
    Sousa, Marta
    Boffito, Marta
    CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (01) : 18 - 27
  • [24] Observational study of drug-drug interactions in oncological inpatients
    Sacramento Diaz-Carrasco, Maria
    Almanchel-Rivadeneyra, Miguel
    Tomas-Luiz, Aina
    Pelegrin-Montesinos, Sandra
    Ramirez-Roig, Cristina
    Jose Fernandez-Avila, Juan
    FARMACIA HOSPITALARIA, 2018, 42 (01) : 10 - 15
  • [25] The prevalence of drug-drug interactions in cancer therapy and the clinical outcomes
    Alnaim, Lamya S.
    Almalki, Hind M.
    Almutairi, Afrah M.
    Salamah, Heba J.
    LIFE SCIENCES, 2022, 310
  • [26] Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions
    Paul Hollywood
    Rachel MacCann
    David Lorigan
    Eoghan de Barra
    Samuel McConkey
    Irish Journal of Medical Science (1971 -), 2020, 189 : 693 - 699
  • [27] Potential Drug-Drug Interactions in Patients with Coronary Artery Disease
    Secoli, S. R.
    Danzi, N.
    Lorenzi-Filho, G.
    Cesar, L.
    Nunes, F.
    Amaro, A.
    Drager, L.
    Reis, A. M. M.
    DRUG SAFETY, 2008, 31 (10) : 921 - 921
  • [28] Cerebral haemorrhage induced by warfarin -: the influence of drug-drug interactions
    Jonsson, Anna K.
    Spigset, Olav
    Jacobsson, Ingela
    Hagg, Staffan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (03) : 309 - 315
  • [29] Potential Drug-Drug Interactions in Patients with coronary Artery Disease
    S. R. Secoli
    N. Danzi
    G. Lorenzi-Filho
    L. César
    F. Nunes
    A. Amaro
    L. Drager
    A. M. M. Reis
    Drug Safety, 2008, 31 : 885 - 885
  • [30] Drug-Drug Interactions and Their Association With Quality of Life in Patients With Hypertension
    Gurel, Nermin
    Uresin, Yagiz
    Sen, Selcuk
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
12345